| Issue Date | Title | Author(s) |
| 2021 | Cerebroprotective effects of 2-ethyl-6-methyl-3-hydroxypyridine-2,6-dichlorophenyl(amino)phenylethanoic acid in the treatment of purulent meningitis | Agarkova, A.; Pokrovskii, M.; Kolesnichenko, P.; Gureev, V.; Gudyrev, O.; Peresypkina, A. |
| 2019 | Correction of Experimental Retinal Ischemia by L-Isomer of Ethylmethylhydroxypyridine Malate | Peresypkina, A.; Pazhinsky, A.; Pokrovskii, M.; Beskhmelnitsyna, E.; Pobeda, A.; Korokin, M. |
| 2022 | Correction of metabolic disturbances by functional food compositions in experimental obesity in CD-1 and agouti-yellow mice | Lebedev, P.; Peresypkina, A.; Gustinovich, V.; Goliusov, A.; Pokrovskii, M. |
| 2020 | Retinoprotective Effect of 2‐Ethyl‐3‐hydroxy‐6‐methylpyridine Nicotinate | Peresypkina, A.; Pokrovskii, M.; Korokin, M.; Soldatov, V.; Pokrovskii, V. |
| 2020 | Studies to Elucidate the Effects of Furostanol Glycosides from Dioscorea deltoidea Cell Culture in a Rat Model of Endothelial Dysfunction | Korokin, M.; Gudyrev, O.; Gureev, V.; Korokina, L.; Peresypkina, A.; Pokrovskaia, T.; Soldatov, V.; Pokrovskii, M. |
| 2020 | Theoretical justification of a purposeful search of potential neurotropic drugs | Semenets, A.; Suleiman, M.; Pokrovskii, M.; Korokin, M.; Soldatov, V. |
